Scalable Production and Purification of Biogenic Nanoparticles
Recent clinical triumphs in gene therapy products have proven their capability to achieve life altering therapeutic results. As such, the market of gene therapy products has garnered major attention from pharmaceutical companies of all sizes.
With a wave of novel modalities, targets and therapeutics entering the market, manufacturing capabilities must evolve to provide adequate and affordable supply.
Situated at the intersection of chemistry, biology and process engineering, we develop novel methods for the scalable production and separation of biogenic nanoparticles like Extracellular Vesicles and Virus-like particles.